---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-001302"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2026-08-10T21:00:22+00:00"
generated_at: "2026-08-10T21:02:16.460109+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lexaria Bioscience receives Nasdaq delisting notice but expects compliance via reverse split

## Summary
- Received Nasdaq delisting notice Aug 4, 2026 for failing to regain $1 minimum bid price within 180-day period.
- Completed reverse stock split Aug 3, 2026 (announced Jul 30); shares now trading above $1 under CUSIP 52886N604.
- Filed hearing request and paid fee to stay delisting; expects to regain compliance before hearing date.
- Company expects shares to continue trading on Nasdaq without interruption.

## SEC filing metadata
- accession: 0001640334-26-001302
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2026-08-10T21:00:22+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033426001302/0001640334-26-001302-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033426001302/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-001302
- JSON: https://secwatch.observer/filing/0001640334-26-001302.json
- Plain text: https://secwatch.observer/filing/0001640334-26-001302.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.